Guggenheim Maintains Buy on SCYNEXIS, Raises Price Target to $33

Benzinga Newsdesk www.benzinga.com Positive 81.9%

Neg 0% Neu 0% Pos 81.9%

Guggenheim analyst Vamil Divan maintains SCYNEXIS (NASDAQ:SCYX) with a Buy and raises the price target from $24 to $33.

Comments

No comments yet. Be the first!